BioCentury
ARTICLE | Financial News

rEVO files for IPO

June 27, 2014 12:04 AM UTC

rEVO Biologics Inc., a subsidiary of LFB S.A. (Les Ulis, France), filed to raise up to $74.8 million in an IPO on NASDAQ underwritten by Piper Jaffray; Guggenheim Securities; Roth Capital Partners; an...